New products are live, and we’ve lowered prices across the catalog. Heads up - high demand means a 2–3 day shipping backlog. Free shipping on orders over $200!
Palm Beach Vitality

Cagrilintide Vial

$300.00

Cagrilintide 5 mL Vial

The Science, Simplified: Cagrilintide is a long-acting synthetic amylin analog studied in research models as a calcitonin-family receptor pathway tool compound.

Product Specifications – Cagrilintide 5 mL Vial (25 mg)

  • Total Cagrilintide: 25 mg
  • Volume: 5 mL vial
  • Concentration: 5 mg/mL
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use liquid vial

Key Research Focus: Used in amylin and dual-amylin/calcitonin receptor (DACRA) pharmacology assays exploring satiety-circuit and metabolic signaling in laboratory systems.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.

Stability & Handling Notes:

  • Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.
  • For lyophilized orders please contact us (minimum order required)
    https://www.palmbeach-vitality.com

Cagrilintide 25 mg / 5 mL (5 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.

How Labs Use This Format: Investigators pipette at 5 mg/mL from this sealed ready-to-use liquid vial for amylin-pathway research. Pen formats may be available in the peptide pens / metabolic pens categories if listed live.

Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records. Cold-pack shipping on qualifying orders.

Cagrilintide 5 mL Vial  Peptide 25mg | Palm Beach Vitality

Cagrilintide Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

  1. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialPubMed 34798060
  2. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight managementPubMed 33894838
  3. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesPubMed 40544432
  4. Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2)PubMed 42251859
  5. Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on metforminPubMed 42251860
Cagrilintide amino acid chain
Cagrilintide — amino acid chain (N→C)